Patent · US Active

Functionalized NANOLUC inhibitors

US10815247B2 · kind B2 · utility

10Cited by

4References

40Claims

0Family size

Assignee

Promega Corporation · US

Inventors

Roderick G. Flemming · McFarland, US
Mary Hall · Waunakee, US
Thomas Machleidt · Madison, US
Poncho Meisenheimer · San Luis Obispo, US
Nidhi Nath · Madison, US
Matthew Robers · Madison, US
Joel R. Walker · Tucson, US
Wenhui Zhou · Madison, US

Key dates

Filing date	Dec 28, 2017
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Aug 13, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N21/763
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Compounds that may inhibit Oplophorus-derived luciferases are disclosed as well as compositions and kits comprising the compounds, and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.